Cardinal Health (NYSE: CAH) reported fourth-quarter fiscal 2026 adjusted earnings of $2.91 per share. This result surpassed the Wall Street consensus estimate of $2.42 per share. Revenue for the period totaled $63.7 billion, falling slightly below analyst forecasts. The Pharmaceutical and Specialty Solutions segment recorded a 21% increase in profit.
The company projects fiscal 2027 adjusted earnings between $12.40 and $12.60 per share. This guidance exceeds the analyst consensus of $12.05 per share. The board of directors approved a new $5.0 billion share repurchase authorization. Cardinal Health repurchased $1.4 billion in shares during fiscal 2026.
Company shares rose approximately 4% in pre-market trading following the announcement.